Aligos Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aligos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Aligos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 3.32M shares, a 92.4% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.32M -40.2M -92.4% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 79.8M +36.3M +83.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 75.7M +32.7M +76.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 3M -39.9M -93% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 43.5M +687K +1.61% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 43.5M +694K +1.62% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 42.9M +245K +0.57% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 42.9M +233K +0.55% Dec 31, 2022 10-K 2024-03-12
Q3 2022 42.8M +204K +0.48% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 42.8M +4.61M +12.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 42.7M +4.55M +11.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 42.7M +4.57M +12% Dec 31, 2021 10-K 2023-03-09
Q3 2021 42.6M +38.5M +938% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 38.2M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 38.1M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 38.1M +34.2M +871% Dec 31, 2020 10-K 2022-03-10
Q3 2020 4.1M Sep 30, 2020 10-Q 2020-11-25
Q4 2019 3.93M Dec 31, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.